The ingredients are lightly dosed, the delivery method is unproven, and the cited research doesnt back up the claims made, especially when it comes to GLP-1-related effects
Side effects determine whether people actually stay on the medication long enough to see those numbers become reality
Average weight loss before stopping was 4.4%, and one year later, this group had actually lost an additional 1.3%
Men with underlying cardiovascular issues must approach this therapy cautiously, and all users should be aware of the dos and donts (no more than one dose per 24 hours, etc.) to use it safely.When used correctly, the safety data is reassuring: side effects are generally transient and manageable, with transient blood pressure increasesbeing the main concern to monitorfda.gov
Cardiovascular safety In terms of cardiovascular safety, IDegLira contains liraglutide, the only Federal Drug Administration (FDA) approved GLP-1RA shown to reduce cardiovascular risk
For the weekly shot, you can make up a missed dose if your next scheduled dose is more than two days away
